SOW
VNDA icon

State of Wyoming’s Vanda Pharmaceuticals VNDA Stock Holding History

State of Wyoming’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,414
Closed -$136K – 2052
2025
Q4 		$136K Sell
15,414
-11,887
-44% -$65.4K 0.01% 1185
2025
Q3 		$136K Buy
+27,301
New +$126K 0.02% 1159
2024
Q2 		– Sell
-11,015
Closed -$45.3K – 1884
2024
Q1 		$45.3K Sell
11,015
-22,967
-68% -$91.9K 0.01% 1333
2023
Q4 		$143K Buy
33,982
+15,189
+81% +$61.3K 0.03% 770
2023
Q3 		$81.2K Buy
18,793
+5,520
+42% +$30.7K 0.02% 1007
2023
Q2 		$87.5K Buy
13,273
+8,522
+179% +$54.6K 0.03% 905
2023
Q1 		$32.3K Sell
4,751
-25,370
-84% -$178K 0.01% 1244
2022
Q4 		$223K Buy
30,121
+9,688
+47% +$94.4K 0.07% 257
2022
Q3 		$202K Buy
20,433
+15,019
+277% +$159K 0.1% 195
2022
Q2 		$59K Sell
5,414
-7,217
-57% -$74.8K 0.04% 839
2022
Q1 		$142K Sell
12,631
-6,318
-33% -$83.1K 0.07% 368
2021
Q4 		$297K Buy
18,949
+9,379
+98% +$163K 0.14% 110
2021
Q3 		$164K Sell
9,570
-612
-6% -$10.7K 0.11% 228
2021
Q2 		$219K Buy
+10,182
New +$182K 0.14% 168

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wyoming's VNDA Position: Q1 2026 in Review

State of Wyoming sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 15,414 shares — an estimated $136K sold.

State of Wyoming first reported a position in VNDA in Q2 2021 and held it in 14 quarters. The position peaked at $297K in Q4 2021. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • State of Wyoming reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 15,414 Vanda Pharmaceuticals shares in Q1 2026, an estimated $136K.
  • State of Wyoming first reported a position in Vanda Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • State of Wyoming's Vanda Pharmaceuticals position peaked at $297K in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.